(ANDE) The Andersons - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0341641035

Grain,Fertilizer,Ethanol,Plant Food,Animal Feed

ANDE EPS (Earnings per Share)

EPS (Earnings per Share) of ANDE over the last years for every Quarter: "2020-09": -0.07, "2020-12": 0.59, "2021-03": 0.46, "2021-06": 1.31, "2021-09": 0.15, "2021-12": 1.14, "2022-03": 0.18, "2022-06": 2.39, "2022-09": 0.5, "2022-12": 0.98, "2023-03": 0.2, "2023-06": 1.52, "2023-09": 0.13, "2023-12": 1.59, "2024-03": 0.16, "2024-06": 1.15, "2024-09": 0.8, "2024-12": 1.36, "2025-03": 0.12, "2025-06": 0.24, "2025-09": 0.84,

ANDE Revenue

Revenue of ANDE over the last years for every Quarter: 2020-09: 1885.586, 2020-12: 2542.917, 2021-03: 2594.719, 2021-06: 3235.805, 2021-09: 2998.824, 2021-12: 3782.702, 2022-03: 3977.954, 2022-06: 4450.617, 2022-09: 4219.325, 2022-12: 4677.488, 2023-03: 3881.238, 2023-06: 4020.183, 2023-09: 3635.691, 2023-12: 3213, 2024-03: 2718.217, 2024-06: 2795.205, 2024-09: 2620.988, 2024-12: 3123.138, 2025-03: 2659.098, 2025-06: 3135.869, 2025-09: 2677.712,
Risk via 10d forecast
Volatility 35.4%
Value at Risk 5%th 55.1%
Reward
Sharpe Ratio 0.21
Alpha Jensen -9.55
Character
Hurst Exponent 0.354
Beta 0.807
Drawdowns 3y
Max DD 46.94%
Mean DD 16.40%

Description: ANDE The Andersons August 14, 2025

The Andersons Inc (NASDAQ:ANDE) is a US-based company operating in the Food Distributors sub-industry. As a food distributor, the companys performance is closely tied to the agricultural and food production sectors, with key economic drivers including commodity prices, crop yields, and demand for grains and other agricultural products.

To evaluate ANDEs financial health, we can look at key performance indicators (KPIs) such as Return on Equity (RoE), which stands at 6.99%. This suggests that the company generates a relatively modest return on shareholder equity. Additionally, the Price-to-Earnings (P/E) ratio of 16.02 and Forward P/E of 20.92 indicate that the companys stock price is influenced by expectations of future earnings growth.

From a valuation perspective, ANDEs Market Cap of $1.288 billion suggests a relatively stable and established player in the industry. To further analyze the companys prospects, we can examine its exposure to commodity price fluctuations, its ability to manage costs and maintain profit margins, and its strategic initiatives to drive growth and expand its market share.

By applying a first-principles approach to analyzing ANDE, we can deconstruct the companys performance into its fundamental drivers, including revenue growth, operating margins, and cash flow generation. This enables us to identify areas of strength and weakness, as well as potential leverage points for improving the companys financial performance.

ANDE Stock Overview

Market Cap in USD 1,705m
Sub-Industry Food Distributors
IPO / Inception 1996-02-20
Return 12m vs S&P 500 -6.78%
Analyst Rating 4.33 of 5

ANDE Dividends

Dividend Yield 1.57%
Yield on Cost 5y 3.77%
Yield CAGR 5y -5.01%
Payout Consistency 99.2%
Payout Ratio 30.5%

ANDE Growth Ratios

CAGR 12.25%
CAGR/Max DD Calmar Ratio 0.26
CAGR/Mean DD Pain Ratio 0.75
Current Volume 372.6k
Average Volume 312.2k

Piotroski VR‑10 (Strict, 0-10) 6.5

Net Income (73.4m TTM) > 0 and > 6% of Revenue (6% = 695.7m TTM)
FCFTA 0.07 (>2.0%) and ΔFCFTA 1.83pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 5.44% (prev 10.16%; Δ -4.72pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.14 (>3.0%) and CFO 452.0m > Net Income 73.4m (YES >=105%, WARN >=100%)
Net Debt (688.7m) to EBITDA (312.1m) ratio: 2.21 <= 3.0 (WARN <= 3.5)
Current Ratio 1.47 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (34.2m) change vs 12m ago -0.51% (target <= -2.0% for YES)
Gross Margin 5.32% (prev 6.16%; Δ -0.84pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 346.9% (prev 334.9%; Δ 12.01pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 3.71 (EBITDA TTM 312.1m / Interest Expense TTM 47.4m) >= 6 (WARN >= 3)

Altman Z'' 3.08

(A) 0.19 = (Total Current Assets 1.96b - Total Current Liabilities 1.33b) / Total Assets 3.30b
(B) 0.30 = Retained Earnings (Balance) 978.7m / Total Assets 3.30b
(C) 0.05 = EBIT TTM 175.8m / Avg Total Assets 3.34b
(D) 0.48 = Book Value of Equity 989.6m / Total Liabilities 2.07b
Total Rating: 3.08 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 54.62

1. Piotroski 6.50pt = 1.50
2. FCF Yield 9.77% = 4.88
3. FCF Margin 2.02% = 0.50
4. Debt/Equity 0.66 = 2.29
5. Debt/Ebitda 2.21 = -0.40
6. ROIC - WACC (= 1.47)% = 1.84
7. RoE 5.57% = 0.46
8. Rev. Trend -81.11% = -6.08
9. EPS Trend -7.54% = -0.38

What is the price of ANDE shares?

As of November 13, 2025, the stock is trading at USD 49.84 with a total of 372,634 shares traded.
Over the past week, the price has changed by +2.81%, over one month by +18.61%, over three months by +25.15% and over the past year by +8.03%.

Is The Andersons a good stock to buy?

Neither. Based on ValueRay´s Fundamental Analyses, The Andersons is currently (November 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 54.62 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ANDE is around 48.89 USD . This means that ANDE is currently overvalued and has a potential downside of -1.91%.

Is ANDE a buy, sell or hold?

The Andersons has received a consensus analysts rating of 4.33. Therefore, it is recommended to buy ANDE.
  • Strong Buy: 2
  • Buy: 0
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the ANDE price?

Issuer Target Up/Down from current
Wallstreet Target Price 51.5 3.4%
Analysts Target Price 51.5 3.4%
ValueRay Target Price 53.6 7.6%

ANDE Fundamental Data Overview November 11, 2025

Market Cap USD = 1.70b (1.70b USD * 1.0 USD.USD)
P/E Trailing = 23.6526
P/E Forward = 20.9205
P/S = 0.147
P/B = 1.0145
P/EG = 2.93
Beta = 0.807
Revenue TTM = 11.60b USD
EBIT TTM = 175.8m USD
EBITDA TTM = 312.1m USD
Long Term Debt = 608.2m USD (from longTermDebt, last fiscal year)
Short Term Debt = 205.2m USD (from shortTermDebt, last quarter)
Debt = 775.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 688.7m USD (from netDebt column, last quarter)
Enterprise Value = 2.39b USD (1.70b + Debt 775.5m - CCE 86.8m)
Interest Coverage Ratio = 3.71 (Ebit TTM 175.8m / Interest Expense TTM 47.4m)
FCF Yield = 9.77% (FCF TTM 233.8m / Enterprise Value 2.39b)
FCF Margin = 2.02% (FCF TTM 233.8m / Revenue TTM 11.60b)
Net Margin = 0.63% (Net Income TTM 73.4m / Revenue TTM 11.60b)
Gross Margin = 5.32% ((Revenue TTM 11.60b - Cost of Revenue TTM 10.98b) / Revenue TTM)
Gross Margin QoQ = 6.30% (prev 6.18%)
Tobins Q-Ratio = 0.73 (Enterprise Value 2.39b / Total Assets 3.30b)
Interest Expense / Debt = 1.62% (Interest Expense 12.6m / Debt 775.5m)
Taxrate = -0.88% (negative due to tax credits) (-228.0k / 25.8m)
NOPAT = 177.4m (EBIT 175.8m * (1 - -0.88%)) [negative tax rate / tax credits]
Current Ratio = 1.47 (Total Current Assets 1.96b / Total Current Liabilities 1.33b)
Debt / Equity = 0.66 (Debt 775.5m / totalStockholderEquity, last quarter 1.18b)
Debt / EBITDA = 2.21 (Net Debt 688.7m / EBITDA 312.1m)
Debt / FCF = 2.95 (Net Debt 688.7m / FCF TTM 233.8m)
Total Stockholder Equity = 1.32b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.23% (Net Income 73.4m / Total Assets 3.30b)
RoE = 5.57% (Net Income TTM 73.4m / Total Stockholder Equity 1.32b)
RoCE = 9.13% (EBIT 175.8m / Capital Employed (Equity 1.32b + L.T.Debt 608.2m))
RoIC = 8.17% (NOPAT 177.4m / Invested Capital 2.17b)
WACC = 6.69% (E(1.70b)/V(2.48b) * Re(8.99%) + D(775.5m)/V(2.48b) * Rd(1.62%) * (1-Tc(-0.01)))
Discount Rate = 8.99% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.25%
[DCF Debug] Terminal Value 66.29% ; FCFE base≈211.7m ; Y1≈139.0m ; Y5≈63.5m
Fair Price DCF = 31.68 (DCF Value 1.07b / Shares Outstanding 33.8m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -7.54 | EPS CAGR: -5.45% | SUE: 1.02 | # QB: 1
Revenue Correlation: -81.11 | Revenue CAGR: -18.36% | SUE: -0.46 | # QB: 0

Additional Sources for ANDE Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle